TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11772119

Group type: EXPERIMENTAL
Intervention: Tianeptine (12.5mg three times daily)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Paroxetine (20mg once daily plus two placebo capsules)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Tianeptine
Number of subjects: 277

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 277
Study: 30165844

Group type: EXPERIMENTAL
Intervention: Once-weekly injection of exenatide
Number of subjects: 171

Group type: COMPARATOR
Intervention: Twice-daily injection of exenatide
Number of subjects: 171
Study: 26550802

Group type: EXPERIMENTAL
Intervention: Easy-to-pronounce anagrams
Number of subjects: 536

Group type: COMPARATOR
Intervention: Hard-to-pronounce anagrams
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Short and long anagrams and nonanagrams
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Presentation timings from 4 down to 0.5 s
Number of subjects: 536
Study: 24334348

Group type: EXPERIMENTAL
Intervention: 30% dextrose (group 1)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sterile water (group 2)
Number of subjects: 25
Study: 22441092

Group type: EXPERIMENTAL
Intervention: Improvised traction splint
Number of subjects: 10

Group type: COMPARATOR
Intervention: HARE traction splint
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sager traction splint
Number of subjects: 10

Group type: COMPARATOR
Intervention: Faretech CT‐EMS traction splint
Number of subjects: 10
Study: 20937187

Group type: EXPERIMENTAL
Intervention: Generic 3-drug fixed-dose combination (3FDC) formulation of rifampicin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of test and reference products
Number of subjects: 0
Study: 18782787

Group type: EXPERIMENTAL
Intervention: Fenoldopam (0.1 microg/kg/min for 72 hours)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (standardized perioperative therapy without fenoldopam)
Number of subjects: 40
Study: 15762940

Group type: EXPERIMENTAL
Intervention: Learning session with the first task before being tested in the second task.
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group that only performed the second task.
Number of subjects: 28
Study: 11952069

Group type: EXPERIMENTAL
Intervention: Continuous midazolam infusion (n = 21)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Diazepam infusion (n = 19)
Number of subjects: 40
Study: 10624759

Group type: EXPERIMENTAL
Intervention: Predictive equations for gas exchange, ventilatory and cardiovascular responses to maximum ramp-incremental cycle ergometry
Number of subjects: 120
Study: 7723546

Group type: EXPERIMENTAL
Intervention: Standard treatment plus antibody 33B3.1 (n = 51)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Standard post‐transplantation immunosuppression (methotrexate plus cyclosporin; n = 50)
Number of subjects: 101
Study: 1952306

Group type: EXPERIMENTAL
Intervention: 37.5 mg methotrimeprazine (Levoprome, Nozinan)
Number of subjects: 74

Group type: COMPARATOR
Intervention: 75 mg meperidine (Demerol) combined with 50 mg dimenhydrinate (Dramamine, Gravol)
Number of subjects: 74
Study: 7035040

Group type: EXPERIMENTAL
Intervention: Indomethacin (25 mg three times daily)
Number of subjects: 12
Study: 30581039

Group type: EXPERIMENTAL
Intervention: Zhang's guideline (intervention group)
Number of subjects: 11615

Group type: COMPARATOR
Intervention: WHO partograph (control group)
Number of subjects: 11615
Study: 28933712

Group type: EXPERIMENTAL
Intervention: Paired-Set (PS) training
Number of subjects: 15

Group type: COMPARATOR
Intervention: Traditional-Set (TS) training
Number of subjects: 15
Study: 25644221

Group type: EXPERIMENTAL
Intervention: Tryptophan (3.0g/day)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 24352352

Group type: EXPERIMENTAL
Intervention: CNS-targeted antiretrovirals (CNS-T)
Number of subjects: 59

Group type: COMPARATOR
Intervention: non-CNS-targeted antiretrovirals (non-CNS-T)
Number of subjects: 59
Study: 22849762

Group type: EXPERIMENTAL
Intervention: Moogoo Udder Cream®
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aqueous cream
Number of subjects: 0
Study: 19384209

Group type: COMPARATOR
Intervention: Facemask
Number of subjects: 11

Group type: COMPARATOR
Intervention: Helmet with same settings
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Helmet with specific settings
Number of subjects: 11
Study: 17545739

Group type: EXPERIMENTAL
Intervention: memantine (20 mg/d)
Number of subjects: 350

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 350
Study: 15887425

Group type: EXPERIMENTAL
Intervention: Ezetimibe (10 mg/d) added to ongoing statin therapy
Number of subjects: 3030

Group type: COMPARATOR
Intervention: Placebo plus ongoing statin therapy
Number of subjects: 3030
Study: 11505962

Group type: EXPERIMENTAL
Intervention: Automatic power flosser
Number of subjects: 70

Group type: COMPARATOR
Intervention: Manual dental floss
Number of subjects: 70
Study: 9489626

Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood progenitor cells (PBPC)
Number of subjects: 392

Group type: COMPARATOR
Intervention: Autologous bone marrow (BM) alone
Number of subjects: 392
Study: 7908877

Group type: EXPERIMENTAL
Intervention: Topical sodium cromoglycate solution and oral oxatomide
Number of subjects: 100

Group type: COMPARATOR
Intervention: Topical placebo solution and oral oxatomide
Number of subjects: 100
Study: 2970555

Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (AG)
Number of subjects: 218

Group type: COMPARATOR
Intervention: High-dose medroxyprogesterone acetate (MPA)
Number of subjects: 218

Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (AG) and High-dose medroxyprogesterone acetate (MPA)
Number of subjects: 218
Study: 30992107

Group type: EXPERIMENTAL
Intervention: NeoMTA Plus
Number of subjects: 28

Group type: COMPARATOR
Intervention: ProRoot MTA
Number of subjects: 28
Study: 28154369

Group type: EXPERIMENTAL
Intervention: Sham feeding with chewing gum 4 times a day after admission
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standard treatment consistent with the guidelines for AP
Number of subjects: 204
Study: 25735442

Group type: EXPERIMENTAL
Intervention: High-risk group (Ɛ4+, n=16)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Low-risk group (Ɛ4-, n=35)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (n=56)
Number of subjects: 107
Study: 23929375

Group type: EXPERIMENTAL
Intervention: Luting and Lining (S3)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ketac Cem (S2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Luting and Lining (S1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Variolink II (S1)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Variolink II (S2)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Rely X ARC (S3)
Number of subjects: 80
Study: 21464481

Group type: EXPERIMENTAL
Intervention: Hybrid THR
Number of subjects: 157

Group type: COMPARATOR
Intervention: Cementless THR
Number of subjects: 157
Study: 19233339

Group type: EXPERIMENTAL
Intervention: Attention-based rehearsal (not specified in dosage or duration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Facilitation of processing at the memorized location (not specified in dosage or duration)
Number of subjects: 0
Study: 17118191

Group type: EXPERIMENTAL
Intervention: Micronutrient mix (288 mg vitamin E, 375 mg vitamin C, 12 mg beta-carotene, 15 mg zinc/day)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Bovine colostrum concentrate (1.2 g/d)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Combination of colostrum and micronutrient mix
Number of subjects: 138

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 138
Study: 14711545

Group type: COMPARATOR
Intervention: Control group (12 fertile patients)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Implantation failure group (35 patients)
Number of subjects: 35
Study: 10735604

Group type: EXPERIMENTAL
Intervention: Fisk Fatigue Severity Score (FFSS)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (nonhepatic disease patients)
Number of subjects: 58
Study: 8612408

Group type: COMPARATOR
Intervention: Dopamine infusion continued
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Dopamine infusion discontinued
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: TRH administration (200 micrograms, two consecutive doses)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: TRH administration (200 micrograms, two consecutive doses) after dopamine withdrawal
Number of subjects: 15
Study: 1424007

Group type: EXPERIMENTAL
Intervention: Photopheresis
Number of subjects: 16

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 16
Study: 2859861

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg for 4 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoprolol (low dosage)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other beta-adrenoceptor blockers (acebutolol, penbutolol, pindolol)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Beta-blockade (general)
Number of subjects: 0
Study: 30797394

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX) implants
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 27876186

Group type: EXPERIMENTAL
Intervention: IOMRI (Intra-operative Magnetic Resonance Imaging), n=25
Number of subjects: 50

Group type: COMPARATOR
Intervention: 2D-F (Two Dimensional Fluoroscopy), n=25
Number of subjects: 50
Study: 26691247

Group type: EXPERIMENTAL
Intervention: DEC 300 mg + Albendazole 400 mg sequential administration
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: DEC 300 mg + Albendazole 400 mg co-administration
Number of subjects: 146

Group type: COMPARATOR
Intervention: DEC 300 mg + Doxycycline 100 mg co-administration
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control regimen DEC 300 mg
Number of subjects: 146
Study: 24422264

Group type: EXPERIMENTAL
Intervention: Formal hand-off process (IPASS the BATON)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Informal hand-off process
Number of subjects: 107
Study: 20925688

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Oral morphine
Number of subjects: 24
Study: 19205853

Group type: EXPERIMENTAL
Intervention: Indirect response (IDR) model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transit (TM) model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inverse Bateman (IBM) model
Number of subjects: 0
Study: 17522765

Group type: EXPERIMENTAL
Intervention: 2% diltiazem ointment
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.2% glyceryl trinitrate (GTN) ointment
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study: 15595331

Group type: EXPERIMENTAL
Intervention: Antiepileptic drugs (AEDs) - phenobarbital, phenytoin, valproic acid
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 12431962

Group type: EXPERIMENTAL
Intervention: High-dose therapy (HDT) followed by involved-field radiotherapy (arm B)
Number of subjects: 312

Group type: COMPARATOR
Intervention: CHOP + etoposide followed by involved-field radiotherapy (arm A)
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Overall survival for all patients
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Event-free survival
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Relapse in arm B
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Secondary neoplasia
Number of subjects: 312
Study: 10630160

Group type: EXPERIMENTAL
Intervention: Conventional irradiation (79 patients)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Hypofractionated irradiation (81 patients)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (80 patients)
Number of subjects: 240
Study: 8611059

Group type: EXPERIMENTAL
Intervention: Obsessive Compulsive Drinking Scale (OCDS)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: OCDS
Number of subjects: 41
Study: 2007102

Group type: EXPERIMENTAL
Intervention: Lidocaine (0.7, 1.85, and 3.7 mg/kg) infused over 15, 45, and 75 minutes
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 6180687

Group type: EXPERIMENTAL
Intervention: Ingestion of up to 300 mg of urushiol over three to six months
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ingestion of urushiol
Number of subjects: 21
Study: 2996444

Group type: EXPERIMENTAL
Intervention: Potassium citrate solution
Number of subjects: 94

Group type: COMPARATOR
Intervention: WHO oral rehydration solution
Number of subjects: 94
Study: 28229572

Group type: EXPERIMENTAL
Intervention: CoQ10 supplementation (200 mg per day for 4 weeks)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (200 mg per day for 4 weeks)
Number of subjects: 21
Study: 26507904

Group type: EXPERIMENTAL
Intervention: Coronary CT angiography care pathway
Number of subjects: 1368

Group type: COMPARATOR
Intervention: Traditional care
Number of subjects: 1368

Group type: EXPERIMENTAL
Intervention: Coronary CT angiography (negative result)
Number of subjects: 1368
Study: 23871132

Group type: EXPERIMENTAL
Intervention: Calcium phosphate (1 g Ca as pentacalcium hydroxy-triphosphate)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo bread
Number of subjects: 10
Study: 22221724

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Escitalopram and Placebo
Number of subjects: 26
Study: 20831671

Group type: EXPERIMENTAL
Intervention: Green banana-supplemented diet
Number of subjects: 2968

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 2968
Study: 18296081

Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting wrap (1.6 microg/mm²) placed around the distal graft anastomosis
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (graft implanted alone)
Number of subjects: 109
Study: 16167790

Group type: EXPERIMENTAL
Intervention: Clonidine 5 microg x kg(‐1) and famotidine 20 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group received oral famotidine alone
Number of subjects: 32
Study: 12797394

Group type: EXPERIMENTAL
Intervention: Oral ofloxacin prophylaxis (200 mg/2x12h)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (standard perioperative antibiotic prophylaxis with 2 g cefotiam)
Number of subjects: 25
Study: 10782653

Group type: EXPERIMENTAL
Intervention: alpha-tocopherol (50 mg)
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: beta-carotene (20 mg)
Number of subjects: 29133

Group type: EXPERIMENTAL
Intervention: both agents
Number of subjects: 29133

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 29133
Study: 8876883

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation with 25 Gy in five cycles during 5-7 days (RT+ group)
Number of subjects: 557

Group type: COMPARATOR
Intervention: Surgery only (RT- group)
Number of subjects: 557
Study: 1793784

Group type: EXPERIMENTAL
Intervention: 400 micrograms misoprostol b.d. after meals
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 400 micrograms misoprostol b.d. before meals
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo before and after meals
Number of subjects: 12
Study: 6186165

Group type: EXPERIMENTAL
Intervention: Beclomethasone nasal spray
Number of subjects: 0
Study: 31442336

Group type: EXPERIMENTAL
Intervention: Training in the overnight‐fasted state (n = 15)
Number of subjects: 30
Study: 29659574

Group type: EXPERIMENTAL
Intervention: School WASH intervention
Number of subjects: 807

Group type: COMPARATOR
Intervention: Control group (comparison schools)
Number of subjects: 807
Study: 26812804

Group type: EXPERIMENTAL
Intervention: Active hypnotic drug
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Gender effect
Number of subjects: 2
Study: 24595916

Group type: EXPERIMENTAL
Intervention: Sexual arousal manipulation
Number of subjects: 0
Study: 22352703

Group type: EXPERIMENTAL
Intervention: Intravenous lipid emulsion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Hartmann's solution
Number of subjects: 8
Study: 20194315

Group type: EXPERIMENTAL
Intervention: Mini-subvastus approach
Number of subjects: 51

Group type: COMPARATOR
Intervention: Mini-midvastus approach
Number of subjects: 51
Study: 17095129

Group type: EXPERIMENTAL
Intervention: Menjugate vaccine stored at room temperature (25+/‐2 degrees C)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Menjugate vaccine stored at 2‐8 degrees C
Number of subjects: 500
Study: 15735184

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 8722

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 8722
Study: 12217264

Group type: EXPERIMENTAL
Intervention: Positive-message group
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Negative-message group
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 118
Study: 9690722

Group type: EXPERIMENTAL
Intervention: Rennie (calcium‐magnesium carbonate) 1360 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: ranitidine 75 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: famotidine 10 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 8080392

Group type: COMPARATOR
Intervention: MMSE items (day, date, recall of apple, recall of penny)
Number of subjects: 1033

Group type: COMPARATOR
Intervention: MMSE items (month, city, spelling world backward, county)
Number of subjects: 1033

Group type: COMPARATOR
Intervention: MMSE items (floor of building, repeating the word table, naming watch, folding paper in half)
Number of subjects: 1033
Study: 2607484

Group type: EXPERIMENTAL
Intervention: Nonaggressive music and nonaggressive lyrics
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Aggressive music and nonaggressive lyrics
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Aggressive music and aggressive lyrics
Number of subjects: 90
Study: 1235478

Group type: EXPERIMENTAL
Intervention: Conventional and hepatitis B immune serum globulin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine screening of donor blood by radioimmunoassay techniques
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial blood use
Number of subjects: 0
Study: 30762416

Group type: EXPERIMENTAL
Intervention: Informed about video recording
Number of subjects: 122

Group type: COMPARATOR
Intervention: Not informed about video recording
Number of subjects: 122
Study: 27977057

Group type: EXPERIMENTAL
Intervention: Otlertuzumab (20 mg/kg) weekly by IV infusion for two 28-day cycles then every 14 days for four 28-day cycles + IV bendamustine (70 mg/m2) on Days 1 and 2 of each cycle for up to six 28-day cycles
Number of subjects: 65

Group type: COMPARATOR
Intervention: Bendamustine alone
Number of subjects: 65
Study: 26041316

Group type: EXPERIMENTAL
Intervention: Large dose remifentanil (0.30 μg/kg/min) + low-dose naloxone (0.25 μg/kg/h)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Small dose remifentanil (0.1 μg/kg/min)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Large dose remifentanil (0.30 μg/kg/min)
Number of subjects: 72
Study: 23841967

Group type: EXPERIMENTAL
Intervention: Gesture Therapy (virtual reality rehabilitation)
Number of subjects: 8
Study: 21501179

Group type: EXPERIMENTAL
Intervention: CFAE ablation plus ostial pulmonary vein isolation (PVI)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Circumferential PVI plus additional lines (linear ablation)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: CFAE ablation plus ostial PVI
Number of subjects: 116
Study: 19675494

Group type: EXPERIMENTAL
Intervention: 4-week training regimen
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (no specific training program)
Number of subjects: 58
Study: 17393625

Group type: EXPERIMENTAL
Intervention: Electro-acupuncture
Number of subjects: 57

Group type: COMPARATOR
Intervention: Simple acupuncture
Number of subjects: 57
Study: 15101612

Group type: EXPERIMENTAL
Intervention: Glyburide
Number of subjects: 75
Study: 11136169

Group type: EXPERIMENTAL
Intervention: Non-dialysis-dependent renal insufficiency (NDDRI)
Number of subjects: 16989

Group type: EXPERIMENTAL
Intervention: Dialysis-dependent patients
Number of subjects: 16989

Group type: COMPARATOR
Intervention: Reference group (creatinine < 2.3 mg/dL)
Number of subjects: 16989
Study: 9264833

Group type: EXPERIMENTAL
Intervention: Immunotherapy with Transfer factor for three months
Number of subjects: 10
Study: 8123406

Group type: EXPERIMENTAL
Intervention: 1.15% isoflurane in oxygen
Number of subjects: 24

Group type: COMPARATOR
Intervention: 0.5% isoflurane with 70% nitrous oxide
Number of subjects: 24

Group type: COMPARATOR
Intervention: Awake group (no intervention)
Number of subjects: 24
Study: 3612828

Group type: EXPERIMENTAL
Intervention: Combination treatment format (communication skills followed by sexual skills)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Basic sex education (4 hours)
Number of subjects: 11
Study: 29489709

Group type: EXPERIMENTAL
Intervention: Cleansing solution and dressing material used before insertion and after removal of SPC.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 27723550

Group type: EXPERIMENTAL
Intervention: Surgical technique with patent tract left at vaginal cuff for drainage (Group II)
Number of subjects: 568
Study: 24142191

Group type: EXPERIMENTAL
Intervention: Bicondylar total knee arthroplasty (TKA) for OA patients
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Bicondylar total knee arthroplasty (TKA) for RA patients
Number of subjects: 128
Study: 22368249

Group type: EXPERIMENTAL
Intervention: Gas chromatograph (GC) using a flame photometric detector
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Portable gas chromatographs (GCs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ZnCl(2) products
Number of subjects: 0
Study: 20851307

Group type: EXPERIMENTAL
Intervention: n-3 PUFA supplementation (1.7 g daily for 3 months)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo (olive oil)
Number of subjects: 206
Study: 17544566

Group type: EXPERIMENTAL
Intervention: Artificial reduction of the transtemporal insonation quality using a thin aluminium foil between the TCD probe and the skin.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Native insonation quality (no intervention).
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Corrupted insonation quality (after intervention).
Number of subjects: 46
Study: 21966763

Group type: EXPERIMENTAL
Intervention: DHEA supplementation (50 mg/day for six months)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: DHEA supplementation
Number of subjects: 20